Hatice ÖNDER, Gül KANYILMAZ, Mustafa AÇIKGÖZ, Esra ACIMAN DEMİREL
Turkish Journal of Oncology - 2026;41(3):193-197
OBJECTIVE: In this study,we aimed to detect olfactory functions of patients with objective method and the factors which can affect these, who referred to our department for definitive radiation therapy. METHODS: This study included the patients without head and neck cancer. All patients functions of odor threshold, discrimination and idenfication were assessed with 'Sniffin Sticks' test before radiation therapy. The overall score is called composite threshold-discrimination-idenfication score. As these scores, <=16 was evaluted as anosmia, 16-30 as hyposmia and >30 normal smell function. RESULTS: This study included 48 patients with a median age of 59 years (30-76 years). With patients who had chemotherapy before radiation therapy, statistically significant olfactory disfunction (hyposmia+anosmia) was determined. 26 of 29 patients (90%) who had chemotherapy, had olfactory disfunction (p=0.02) and 7 of 10 patients (70%) who had normal smell functions had no prior chemotherapy (p=0.04). As multivariant analysis, increased age (OR:1.33, 95% CI 1.08-1.64;p=0.007) and to be treated with chemotherapy (OR:32.95, 95% CI 1.35-801.45; p=0.032) were significant factors in terms of olfactory disfunction. CONCLUSION: In this study, we established olfactory disfunction at 79% patients who were planned definitive radiotherapy. As multivariant analysis; increasing age and to be treated with chemotherapy were statistically significant parameters as to olfactory disfunction .The patients with cancer , smell and taste disfunctions can occur frequently and to be aware of these pathologies is important for providing required treatment support.
